Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: March 3, 2026, 1:02 pm
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 526299 | NSE: MPHASIS

Mphasis Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 3, 2026, 1:02 pm

Market Cap 43,005 Cr.
Current Price 2,256
Intrinsic Value₹1,857.74
High / Low 3,037/2,025
Stock P/E23.6
Book Value 505
Dividend Yield2.53 %
ROCE22.7 %
ROE18.2 %
Face Value 10.0
PEG Ratio5.34

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Mphasis Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Mphasis Ltd 43,005 Cr. 2,256 3,037/2,02523.6 5052.53 %22.7 %18.2 % 10.0
Tata Elxsi Ltd 27,717 Cr. 4,449 6,735/4,31843.9 4341.69 %36.3 %29.3 % 10.0
Zensar Technologies Ltd 12,927 Cr. 568 895/52817.0 1882.29 %21.3 %16.4 % 2.00
Sonata Software Ltd 7,298 Cr. 260 464/25015.8 63.21.69 %29.1 %27.3 % 1.00
Newgen Software Technologies Ltd 6,942 Cr. 488 1,379/45322.6 1031.03 %27.8 %22.4 % 10.0
Industry Average98,873.94 Cr685.9739.61156.220.91%20.61%18.63%7.00

All Competitor Stocks of Mphasis Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 3,5063,3613,2523,2763,3383,4123,4223,5363,5613,7103,7323,9024,003
Expenses 2,8892,7632,6652,6812,7372,7732,8042,8882,8833,0073,0303,1803,252
Operating Profit 618599587596601639619648678703703722750
OPM % 18%18%18%18%18%19%18%18%19%19%19%18%19%
Other Income 40435049546474596360817527
Interest 24242434535050403936424441
Depreciation 82838789103131105104132135132128143
Profit before tax 551534526522499522537563569591610625593
Tax % 25%24%25%25%25%25%25%25%25%24%28%25%25%
Net Profit 412405396392374393405423428446442469442
EPS in Rs 21.8921.5121.0120.7819.7920.8121.3922.3722.5623.4923.2224.6523.21

Last Updated: February 4, 2026, 11:03 pm

Below is a detailed analysis of the quarterly data for Mphasis Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

  • For Sales, as of Dec 2025, the value is 4,003.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,902.00 Cr. (Sep 2025) to 4,003.00 Cr., marking an increase of 101.00 Cr..
  • For Expenses, as of Dec 2025, the value is 3,252.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,180.00 Cr. (Sep 2025) to 3,252.00 Cr., marking an increase of 72.00 Cr..
  • For Operating Profit, as of Dec 2025, the value is 750.00 Cr.. The value appears strong and on an upward trend. It has increased from 722.00 Cr. (Sep 2025) to 750.00 Cr., marking an increase of 28.00 Cr..
  • For OPM %, as of Dec 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Sep 2025) to 19.00%, marking an increase of 1.00%.
  • For Other Income, as of Dec 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Sep 2025) to 27.00 Cr., marking a decrease of 48.00 Cr..
  • For Interest, as of Dec 2025, the value is 41.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 44.00 Cr. (Sep 2025) to 41.00 Cr., marking a decrease of 3.00 Cr..
  • For Depreciation, as of Dec 2025, the value is 143.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Sep 2025) to 143.00 Cr., marking an increase of 15.00 Cr..
  • For Profit before tax, as of Dec 2025, the value is 593.00 Cr.. The value appears to be declining and may need further review. It has decreased from 625.00 Cr. (Sep 2025) to 593.00 Cr., marking a decrease of 32.00 Cr..
  • For Tax %, as of Dec 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 25.00%.
  • For Net Profit, as of Dec 2025, the value is 442.00 Cr.. The value appears to be declining and may need further review. It has decreased from 469.00 Cr. (Sep 2025) to 442.00 Cr., marking a decrease of 27.00 Cr..
  • For EPS in Rs, as of Dec 2025, the value is 23.21. The value appears to be declining and may need further review. It has decreased from 24.65 (Sep 2025) to 23.21, marking a decrease of 1.44.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 2:46 am

MetricMar 2014n n 5mMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 2,5945,7956,0816,0766,5467,7318,8449,72211,96113,79813,27914,23015,347
Expenses 2,1544,9255,2185,1085,4836,4077,1937,9199,84411,36510,85711,58312,470
Operating Profit 4408708639691,0621,3241,6501,8032,1182,4342,4222,6472,877
OPM % 17%15%14%16%16%17%19%19%18%18%18%19%19%
Other Income 44194172223149177178133160162218255242
Interest 11282414131781637497161166163
Depreciation 5098121797176232242291325410476538
Profit before tax 4229388901,0991,1281,4071,5151,6311,9132,1732,0682,2602,419
Tax % 28%28%29%28%26%24%22%25%25%25%25%25%
Net Profit 3036756327928381,0731,1851,2171,4311,6381,5551,7021,799
EPS in Rs 14.4032.1030.0537.6243.3457.6463.5265.0676.1986.9482.2789.5594.57
Dividend Payout % 49%50%67%45%46%47%55%100%60%58%67%64%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-6.37%25.32%5.81%28.04%10.44%2.70%17.58%14.47%-5.07%9.45%
Change in YoY Net Profit Growth (%)0.00%31.69%-19.51%22.23%-17.60%-7.74%14.88%-3.12%-19.53%14.52%

Mphasis Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:10%
3 Years:6%
TTM:8%
Compounded Profit Growth
10 Years:10%
5 Years:7%
3 Years:6%
TTM:11%
Stock Price CAGR
10 Years:22%
5 Years:20%
3 Years:12%
1 Year:-7%
Return on Equity
10 Years:18%
5 Years:20%
3 Years:19%
Last Year:18%

Last Updated: September 5, 2025, 11:20 am

Balance Sheet

Last Updated: December 4, 2025, 1:40 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 210210210210193186187187188188189190190
Reserves 4,9055,2705,6455,9425,2895,0645,6436,3406,7557,7468,6069,4389,432
Borrowings 5405754612603905435715135271981,5441,1161,979
Other Liabilities 1,3201,3121,0928891,1091,5762,3392,3243,2143,3733,6624,0004,672
Total Liabilities 6,9747,3677,4087,3016,9807,3688,7409,36510,68411,50614,00014,74416,273
Fixed Assets 2,4042,3341,5971,9211,8842,1703,0133,0203,7744,0605,5335,7816,091
CWIP 6205612317311326101
Investments 1,8151,4432,1222,3961,7821,3291,3261,8461,8131,7533,0902,2081,464
Other Assets 2,7483,5693,6332,9833,3123,8664,3844,4965,0875,6625,3166,7548,718
Total Assets 6,9747,3677,4087,3016,9807,3688,7409,36510,68411,50614,00014,74416,273

Below is a detailed analysis of the balance sheet data for Mphasis Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 190.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 190.00 Cr..
  • For Reserves, as of Sep 2025, the value is 9,432.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9,438.00 Cr. (Mar 2025) to 9,432.00 Cr., marking a decrease of 6.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 1,979.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,116.00 Cr. (Mar 2025) to 1,979.00 Cr., marking an increase of 863.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 4,672.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,000.00 Cr. (Mar 2025) to 4,672.00 Cr., marking an increase of 672.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 16,273.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14,744.00 Cr. (Mar 2025) to 16,273.00 Cr., marking an increase of 1,529.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 6,091.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,781.00 Cr. (Mar 2025) to 6,091.00 Cr., marking an increase of 310.00 Cr..
  • For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
  • For Investments, as of Sep 2025, the value is 1,464.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,208.00 Cr. (Mar 2025) to 1,464.00 Cr., marking a decrease of 744.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 8,718.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,754.00 Cr. (Mar 2025) to 8,718.00 Cr., marking an increase of 1,964.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 16,273.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,744.00 Cr. (Mar 2025) to 16,273.00 Cr., marking an increase of 1,529.00 Cr..

Notably, the Reserves (9,432.00 Cr.) exceed the Borrowings (1,979.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 1986167316647239501,3211,4551,7161,4622,1801,905
Cash from Investing Activity + 225-380-175267507280142-810-271196-2,49632
Cash from Financing Activity + -429-186-568-710-1,380-1,342-825-861-1,389-1,44077-1,756
Net Cash Flow -750-12221-149-112638-21756217-239181

Free Cash Flow

MonthMar 2014n n 5mMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow440.00295.00402.00709.00-389.00-542.00-570.00-512.00-525.00-196.001.001.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 1093939384545343568676773
Inventory Days
Days Payable
Cash Conversion Cycle 1093939384545343568676773
Working Capital Days 22-5202921196151319-27-22
ROCE %16%15%18%19%24%26%25%27%29%24%23%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 55.63%55.58%55.57%55.52%55.45%40.35%40.32%40.23%40.14%40.10%40.10%30.59%
FIIs 17.72%17.19%16.60%15.72%14.84%18.32%18.25%20.78%20.61%18.99%18.52%19.79%
DIIs 21.00%21.05%22.55%23.71%24.63%35.84%36.87%34.62%34.91%36.51%37.08%45.26%
Public 5.65%6.19%5.27%5.06%5.08%5.49%4.54%4.38%4.34%4.40%4.31%4.36%
Others 0.00%0.00%0.00%0.00%0.01%0.00%0.03%0.00%0.00%0.00%0.00%0.00%
No. of Shareholders 1,69,2151,77,0131,53,7921,48,4281,47,3501,67,5931,49,3181,43,7001,39,8131,52,6021,45,6111,40,263

Shareholding Pattern Chart

No. of Shareholders

Mphasis Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Kotak Midcap Fund 7,771,095 3.63 2144.056,593,8802025-12-15 04:18:4017.85%
HDFC Mid Cap Fund 5,033,657 1.51 1388.794,433,6572026-02-23 00:45:1013.53%
ICICI Prudential Technology Fund 2,349,600 4.2 648.252,377,9752026-02-23 00:45:10-1.19%
Kotak Large & Midcap Fund 2,200,000 2.02 606.98N/AN/AN/A
Kotak Multicap Fund 1,652,887 2.01 456.031,702,8872025-12-15 04:18:40-2.94%
ICICI Prudential Focused Equity Fund 1,553,625 2.87 428.65N/AN/AN/A
HDFC Large and Mid Cap Fund 1,537,999 1.5 424.33N/AN/AN/A
HDFC Balanced Advantage Fund 1,257,231 0.32 346.87N/AN/AN/A
DSP Mid Cap Fund 1,246,962 1.81 344.04N/AN/AN/A
Kotak Balanced Advantage Fund 1,110,796 1.75 306.471,154,5212026-02-23 00:45:10-3.79%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 89.8782.4287.0576.3865.18
Diluted EPS (Rs.) 89.3681.8386.3775.6164.43
Cash EPS (Rs.) 114.61103.98104.2091.6677.98
Book Value[Excl.RevalReserv]/Share (Rs.) 506.53465.31421.15369.66348.93
Book Value[Incl.RevalReserv]/Share (Rs.) 506.53465.31421.15369.66348.93
Revenue From Operations / Share (Rs.) 748.62702.55732.38636.84519.77
PBDIT / Share (Rs.) 152.67139.66137.76121.29103.49
PBIT / Share (Rs.) 127.61117.94120.50105.8190.56
PBT / Share (Rs.) 118.90109.43115.34101.8487.17
Net Profit / Share (Rs.) 89.5582.2686.9476.1865.05
NP After MI And SOA / Share (Rs.) 89.5582.2686.9476.1865.05
PBDIT Margin (%) 20.3919.8718.8119.0419.91
PBIT Margin (%) 17.0416.7816.4516.6117.42
PBT Margin (%) 15.8815.5715.7415.9916.77
Net Profit Margin (%) 11.9611.7011.8711.9612.51
NP After MI And SOA Margin (%) 11.9611.7011.8711.9612.51
Return on Networth / Equity (%) 17.6717.6720.6420.6018.64
Return on Capital Employeed (%) 23.1922.4525.7625.3223.34
Return On Assets (%) 11.4111.0014.1013.3012.94
Total Debt / Equity (X) 0.110.170.020.070.07
Asset Turnover Ratio (%) 0.981.031.050.900.75
Current Ratio (X) 1.571.582.131.962.40
Quick Ratio (X) 1.571.582.131.962.40
Dividend Payout Ratio (NP) (%) 61.1060.6452.8285.0853.66
Dividend Payout Ratio (CP) (%) 47.7447.9744.0770.7144.76
Earning Retention Ratio (%) 38.9039.3647.1814.9246.34
Cash Earning Retention Ratio (%) 52.2652.0355.9329.2955.24
Interest Coverage Ratio (X) 17.5316.4126.6930.6230.53
Interest Coverage Ratio (Post Tax) (X) 11.2810.6717.8420.2320.19
Enterprise Value (Cr.) 47038.6245867.3832991.4162998.7932810.46
EV / Net Operating Revenue (X) 3.313.452.395.273.37
EV / EBITDA (X) 16.2117.3812.7127.6516.95
MarketCap / Net Operating Revenue (X) 3.343.402.455.303.43
Retention Ratios (%) 38.8939.3547.1714.9146.33
Price / BV (X) 4.945.134.279.135.11
Price / Net Operating Revenue (X) 3.343.402.455.303.43
EarningsYield 0.030.030.040.020.03

After reviewing the key financial ratios for Mphasis Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 89.87. This value is within the healthy range. It has increased from 82.42 (Mar 24) to 89.87, marking an increase of 7.45.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 89.36. This value is within the healthy range. It has increased from 81.83 (Mar 24) to 89.36, marking an increase of 7.53.
  • For Cash EPS (Rs.), as of Mar 25, the value is 114.61. This value is within the healthy range. It has increased from 103.98 (Mar 24) to 114.61, marking an increase of 10.63.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 506.53. It has increased from 465.31 (Mar 24) to 506.53, marking an increase of 41.22.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 506.53. It has increased from 465.31 (Mar 24) to 506.53, marking an increase of 41.22.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 748.62. It has increased from 702.55 (Mar 24) to 748.62, marking an increase of 46.07.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 152.67. This value is within the healthy range. It has increased from 139.66 (Mar 24) to 152.67, marking an increase of 13.01.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 127.61. This value is within the healthy range. It has increased from 117.94 (Mar 24) to 127.61, marking an increase of 9.67.
  • For PBT / Share (Rs.), as of Mar 25, the value is 118.90. This value is within the healthy range. It has increased from 109.43 (Mar 24) to 118.90, marking an increase of 9.47.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 89.55. This value is within the healthy range. It has increased from 82.26 (Mar 24) to 89.55, marking an increase of 7.29.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 89.55. This value is within the healthy range. It has increased from 82.26 (Mar 24) to 89.55, marking an increase of 7.29.
  • For PBDIT Margin (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has increased from 19.87 (Mar 24) to 20.39, marking an increase of 0.52.
  • For PBIT Margin (%), as of Mar 25, the value is 17.04. This value is within the healthy range. It has increased from 16.78 (Mar 24) to 17.04, marking an increase of 0.26.
  • For PBT Margin (%), as of Mar 25, the value is 15.88. This value is within the healthy range. It has increased from 15.57 (Mar 24) to 15.88, marking an increase of 0.31.
  • For Net Profit Margin (%), as of Mar 25, the value is 11.96. This value exceeds the healthy maximum of 10. It has increased from 11.70 (Mar 24) to 11.96, marking an increase of 0.26.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.96. This value is within the healthy range. It has increased from 11.70 (Mar 24) to 11.96, marking an increase of 0.26.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 17.67. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 17.67.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 23.19. This value is within the healthy range. It has increased from 22.45 (Mar 24) to 23.19, marking an increase of 0.74.
  • For Return On Assets (%), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 11.00 (Mar 24) to 11.41, marking an increase of 0.41.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.03 (Mar 24) to 0.98, marking a decrease of 0.05.
  • For Current Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.58 (Mar 24) to 1.57, marking a decrease of 0.01.
  • For Quick Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.58 (Mar 24) to 1.57, marking a decrease of 0.01.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 61.10. This value exceeds the healthy maximum of 50. It has increased from 60.64 (Mar 24) to 61.10, marking an increase of 0.46.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 47.74. This value is within the healthy range. It has decreased from 47.97 (Mar 24) to 47.74, marking a decrease of 0.23.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 38.90. This value is below the healthy minimum of 40. It has decreased from 39.36 (Mar 24) to 38.90, marking a decrease of 0.46.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 52.26. This value is within the healthy range. It has increased from 52.03 (Mar 24) to 52.26, marking an increase of 0.23.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 17.53. This value is within the healthy range. It has increased from 16.41 (Mar 24) to 17.53, marking an increase of 1.12.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from 10.67 (Mar 24) to 11.28, marking an increase of 0.61.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 47,038.62. It has increased from 45,867.38 (Mar 24) to 47,038.62, marking an increase of 1,171.24.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.31. This value exceeds the healthy maximum of 3. It has decreased from 3.45 (Mar 24) to 3.31, marking a decrease of 0.14.
  • For EV / EBITDA (X), as of Mar 25, the value is 16.21. This value exceeds the healthy maximum of 15. It has decreased from 17.38 (Mar 24) to 16.21, marking a decrease of 1.17.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 3.40 (Mar 24) to 3.34, marking a decrease of 0.06.
  • For Retention Ratios (%), as of Mar 25, the value is 38.89. This value is within the healthy range. It has decreased from 39.35 (Mar 24) to 38.89, marking a decrease of 0.46.
  • For Price / BV (X), as of Mar 25, the value is 4.94. This value exceeds the healthy maximum of 3. It has decreased from 5.13 (Mar 24) to 4.94, marking a decrease of 0.19.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 3.40 (Mar 24) to 3.34, marking a decrease of 0.06.
  • For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Mphasis Ltd as of March 5, 2026 is: ₹1,779.16

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 5, 2026, Mphasis Ltd is Overvalued by 21.14% compared to the current share price ₹2,256.00

Intrinsic Value of Mphasis Ltd as of March 5, 2026 is: ₹1,857.74

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 5, 2026, Mphasis Ltd is Overvalued by 17.65% compared to the current share price ₹2,256.00

Last 5 Year EPS CAGR: 4.42%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 20.50%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 9.17, which is a positive sign.
  3. The company has higher reserves (6,621.15 cr) compared to borrowings (709.00 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (8.85 cr) and profit (174.15 cr) over the years.
  1. The stock has a high average Cash Conversion Cycle of 54.92, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mphasis Ltd:
    1. Net Profit Margin: 11.96%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 23.19% (Industry Average ROCE: 20.61%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 17.67% (Industry Average ROE: 18.63%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 11.28
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.57
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 23.6 (Industry average Stock P/E: 39.61)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.11
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

MphasiS Ltd. is a Public Limited Listed company incorporated on 10/08/1992 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L30007KA1992PLC025294 and registration number is 025294. Currently Company is involved in the business activities of Computer programming activities. Company's Total Operating Revenue is Rs. 9271.05 Cr. and Equity Capital is Rs. 190.08 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
IT Consulting & SoftwareBagmane World Technology Center, Bengaluru Karnataka 560048Contact not found
Management
NamePosition Held
Ms. Jan Kathleen HierChairman
Mr. Nitin RakeshManaging Director & CEO
Mr. Marshall Jan LuxNon Executive Director
Mr. Amit DalmiaNon Executive Director
Mr. Amit DixitNon Executive Director
Mr. David Lawrence JohnsonNon Executive Director
Ms. Courtney Della CavaNon Executive Director
Mr. Kabir MathurNon Executive Director
Mr. Pankaj SoodNon Executive Director
Mr. Girish ParanjpeIndependent Director
Ms. Maureen Anne ErasmusIndependent Director
Mr. Sunil GulatiIndependent Director

FAQ

What is the intrinsic value of Mphasis Ltd?

Mphasis Ltd's intrinsic value (as of 05 March 2026) is ₹1857.74 which is 17.65% lower the current market price of ₹2,256.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹43,005 Cr. market cap, FY2025-2026 high/low of ₹3,037/2,025, reserves of ₹9,432 Cr, and liabilities of ₹16,273 Cr.

What is the Market Cap of Mphasis Ltd?

The Market Cap of Mphasis Ltd is 43,005 Cr..

What is the current Stock Price of Mphasis Ltd as on 05 March 2026?

The current stock price of Mphasis Ltd as on 05 March 2026 is ₹2,256.

What is the High / Low of Mphasis Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Mphasis Ltd stocks is ₹3,037/2,025.

What is the Stock P/E of Mphasis Ltd?

The Stock P/E of Mphasis Ltd is 23.6.

What is the Book Value of Mphasis Ltd?

The Book Value of Mphasis Ltd is 505.

What is the Dividend Yield of Mphasis Ltd?

The Dividend Yield of Mphasis Ltd is 2.53 %.

What is the ROCE of Mphasis Ltd?

The ROCE of Mphasis Ltd is 22.7 %.

What is the ROE of Mphasis Ltd?

The ROE of Mphasis Ltd is 18.2 %.

What is the Face Value of Mphasis Ltd?

The Face Value of Mphasis Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Mphasis Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports